Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Assets (2016 - 2025)

Historic Assets for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $1.6 billion.

  • National Healthcare's Assets rose 60.38% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 60.38%. This contributed to the annual value of $1.5 billion for FY2024, which is 1629.8% up from last year.
  • National Healthcare's Assets amounted to $1.6 billion in Q3 2025, which was up 60.38% from $1.6 billion recorded in Q2 2025.
  • National Healthcare's 5-year Assets high stood at $1.6 billion for Q3 2025, and its period low was $1.3 billion during Q1 2023.
  • Its 5-year average for Assets is $1.4 billion, with a median of $1.4 billion in 2021.
  • Its Assets has fluctuated over the past 5 years, first crashed by 911.69% in 2022, then surged by 2190.49% in 2024.
  • National Healthcare's Assets (Quarter) stood at $1.4 billion in 2021, then fell by 9.12% to $1.3 billion in 2022, then rose by 2.77% to $1.3 billion in 2023, then rose by 16.3% to $1.5 billion in 2024, then grew by 3.13% to $1.6 billion in 2025.
  • Its Assets was $1.6 billion in Q3 2025, compared to $1.6 billion in Q2 2025 and $1.5 billion in Q1 2025.